Chronic hepatitis B in hepatocarcinogenesis
Author(s) -
N H Park,
In Hye Song,
Y-H Chung
Publication year - 2006
Publication title -
postgraduate medical journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.568
H-Index - 99
eISSN - 1469-0756
pISSN - 0032-5473
DOI - 10.1136/pgmj.2006.047431
Subject(s) - hepatocellular carcinoma , medicine , hepatitis b virus , cirrhosis , liver cancer , hepatitis b , carcinogen , hepatitis , cancer , chronic hepatitis , virus , virology , immunology , biology , genetics
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world, and has a wide geographical variation. Eighty per cent of HCC is attributed to hepatitis B virus (HBV). The predominant carcinogenic mechanism of HBV associated HCC is through the process of liver cirrhosis, but direct oncogenic effects of HBV may also contribute. Prevention of HBV infections as well as effective treatment of chronic hepatitis B is still needed for the global control of HBV associated HCC. Continued investigation of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in the liver.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom